These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32464235)
21. Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors. Khalili M; Zhou H; Thadi A; Daniels L; Fan Z; Morano WF; Ang J; Goldstein E; Polyak B; Mapow BC; Cheng H; Bowne WB Ann Surg Oncol; 2020 Jan; 27(1):76-84. PubMed ID: 31187366 [TBL] [Abstract][Full Text] [Related]
22. [Study on delivery efficiency and cytotoxicity of Hela cells with mPEG-PLGA-BSA-FITC-NPs nanocarrier]. Chen Z; Wu N; Deng X; Wang F; Li K; Guo W; Liu R; Yuan S; Zhang J; Yang S Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):48-51, 56. PubMed ID: 25966555 [TBL] [Abstract][Full Text] [Related]
23. Development of Targeted Nanoscale Drug Delivery System for Osteoarthritic Cartilage Tissue. Jiang T; Kan HM; Rajpura K; Carbone EJ; Li Y; Lo KW J Nanosci Nanotechnol; 2018 Apr; 18(4):2310-2317. PubMed ID: 29442897 [TBL] [Abstract][Full Text] [Related]
24. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. Lu L; Yaszemski MJ; Mikos AG J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800 [TBL] [Abstract][Full Text] [Related]
25. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells. Liu CW; Lin WJ J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387 [TBL] [Abstract][Full Text] [Related]
26. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer. Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372 [TBL] [Abstract][Full Text] [Related]
27. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
28. Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery. Wei K; Peng X; Zou F Int J Pharm; 2014 Apr; 464(1-2):225-33. PubMed ID: 24463073 [TBL] [Abstract][Full Text] [Related]
29. In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles. Bommana MM; Kirthivasan B; Squillante E Drug Deliv; 2012 Aug; 19(6):298-306. PubMed ID: 22928708 [TBL] [Abstract][Full Text] [Related]
30. Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma. Li H; Tong Y; Bai L; Ye L; Zhong L; Duan X; Zhu Y Int J Biol Macromol; 2018 Feb; 107(Pt A):204-211. PubMed ID: 28863897 [TBL] [Abstract][Full Text] [Related]
31. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment. Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458 [TBL] [Abstract][Full Text] [Related]
32. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411 [TBL] [Abstract][Full Text] [Related]
33. Selective Nanoparticle Targeting of the Renal Tubules. Williams RM; Shah J; Tian HS; Chen X; Geissmann F; Jaimes EA; Heller DA Hypertension; 2018 Jan; 71(1):87-94. PubMed ID: 29133360 [TBL] [Abstract][Full Text] [Related]
34. Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells. Paka GD; Ramassamy C Mol Pharm; 2017 Jan; 14(1):93-106. PubMed ID: 27744707 [TBL] [Abstract][Full Text] [Related]
35. Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. Xia H; Gao X; Gu G; Liu Z; Hu Q; Tu Y; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H Int J Pharm; 2012 Oct; 436(1-2):840-50. PubMed ID: 22841849 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
37. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688 [TBL] [Abstract][Full Text] [Related]
38. Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation. Hou Y; Zhu L; Ye X; Ke Q; Zhang Q; Xie X; Piao JG; Wei Y J Nanobiotechnology; 2024 Jun; 22(1):305. PubMed ID: 38822364 [TBL] [Abstract][Full Text] [Related]
39. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135 [TBL] [Abstract][Full Text] [Related]
40. PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium. Gholizadeh S; Kamps JAAM; Hennink WE; Kok RJ Int J Pharm; 2018 Sep; 548(2):747-758. PubMed ID: 29042337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]